NFE2L2 and malaria: Similarly, based on the observation that sickle human hemoglobin confers tolerance to malaria, it was proposed that modulation of HO-1 via the transcription factor NF-E2-related factor 2 (Nrf2) might be a therapeutic target for treating cerebral malaria [15].